A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells

The only licensed vaccine Mycobacterium bovis Bacillus Calmette–Guérin (BCG) cannot prevent the prevalence of tuberculosis (TB), which remains a major public health problem worldwide. A more effective TB vaccine than BCG is urgently needed. Subunit vaccine is a promising strategy, and suitable adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qi, Wang, Xiaochun, Fan, Xionglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436497/
https://www.ncbi.nlm.nih.gov/pubmed/28572807
http://dx.doi.org/10.3389/fimmu.2017.00585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436497/
https://www.ncbi.nlm.nih.gov/pubmed/28572807
http://dx.doi.org/10.3389/fimmu.2017.00585

Ejemplares similares